Press release
On-Body Drug Delivery Devices Market to Reach USD 46.7 Billion by 2030
On-Body Drug Delivery Devices
According to Exactitude Consultancy, the market is projected to surge to USD 46.7 billion by 2030, rising from USD 19.1 billion in 2023, representing a CAGR of 12.4% from 2024 to 2030.
Wearable and on-body delivery devices-such as patch injectors, bolus injectors, auto-injectors, insulin pods, and smart connected wearables-are transforming chronic disease management, reducing hospital burden, and improving patient adherence worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73462
Key Takeaways
• Market Size 2023: USD 19.1 billion
• Market Size 2030: USD 46.7 billion
• CAGR (2024-2030): 12.4%
• Top Growth Drivers: Biologics delivery, chronic disease prevalence, at-home care models, and connected health devices.
• Emerging White Spaces: Electronic connectivity, multi-drug platforms, AI-assisted dosing, and reusable patch injectors.
Market Story
On-body drug delivery devices have seen rapid adoption as the global healthcare ecosystem shifts toward decentralised care. These devices allow patients to self-administer high-viscosity biologics, hormones, oncology therapies, and insulin without requiring clinical supervision.
The pharmaceutical pipeline is increasingly dominated by biologics and specialty therapeutics, many requiring controlled, precise, and continuous drug delivery-making wearable injectors essential. Hospitals and payers are embracing these devices to reduce clinical visits, boost patient compliance, and manage high-burden chronic conditions.
White space opportunities are evolving across:
• Smart, connected wearables for dosing tracking
• AI-based adherence monitoring
• Micro-pump & microneedle-based devices
• High-viscosity biologics delivery systems
• Electronically controlled release mechanisms
Manufacturers are heavily investing in intuitive, patient-friendly, error-proof device designs that support drug differentiation and lifecycle management strategies for pharma companies.
Market Segments
By Type of Device
• On-Body Wearable Injectors (Patch Pumps, Pod Injectors)
• Bolus Injectors
• Auto-injector-based Wearables
• Microneedle Patch Systems
• Smart Connected On-Body Delivery Systems
Wearable injectors represent the largest segment, driven by biologics and long-acting injectables.
By Application
• Diabetes (Insulin Delivery, GLP-1 Therapies)
• Oncology
• Autoimmune Disorders (RA, IBD, Psoriasis)
• Cardiovascular Disorders
• Hormone Therapies
• Pain Management
• Other Chronic Conditions
Diabetes and autoimmune diseases dominate usage due to need for frequent self-administration.
By Technology
• Electromechanical Systems
• Mechanical (Spring-Based) Systems
• Micropump & Reservoir-Based Systems
• Connected/IoT-Enabled Delivery Devices
Electromechanical and connected platforms show highest growth due to precision and remote monitoring benefits.
By Distribution Channel
• Hospitals & Specialty Clinics
• Retail Pharmacies
• Online Pharmacies
• Home Care Settings
Home-care channels are expanding fastest due to the shift toward self-care.
By End-User
• Pharma & Biotech Companies
• Patients & Homecare Users
• Healthcare Providers
• Clinical Research & Trials Organizations
• Device OEMs / Med-Tech Companies
Explore Full Report here: https://exactitudeconsultancy.com/reports/73462/on-body-drug-delivery-devices-white-spaces-analysis-market
Recent Industry Developments
• 2024 - Insulet expanded Omnipod platform compatibility for new GLP-1 and basal insulin therapies.
• 2024 - BD & Pharm-as-a-Service partnerships targeted wearable drug delivery for biologics under development.
• 2023 - Ypsomed & Jabil launched next-gen patch injectors for high-viscosity formulations.
• 2023 - Medtronic advanced hybrid closed-loop insulin systems integrating on-body sensors.
• 2023 - Enable Injections scaled up production of subcutaneous wearable bolus injectors for biopharma partners.
Expert Quote
"Wearable drug delivery devices are redefining treatment pathways by enabling self-administration of high-value biologics. Companies that integrate connectivity, patient usability, and AI insights into on-body platforms will lead the next decade of digital therapeutics and personalized care."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
1. Chronic Disease Burden
Diabetes, autoimmune disorders, and oncology cases continue to rise, driving need for reliable at-home therapy administration.
2. Biologics Boom
High-viscosity biologics require advanced wearable injectors for safe and effective delivery.
3. Shift Toward At-Home Care
Cost savings and convenience for patients and healthcare systems contribute to widespread adoption.
4. Technological Innovation
Integration of Bluetooth, IoT, smart sensors, and AI-driven adherence analytics creates new value propositions.
5. Improved Patient Compliance
Wearable systems reduce fear of needles and minimize dosing errors.
Forecast Outlook (2024-2030)
The On-Body Drug Delivery Devices Market will grow rapidly due to:
• Increasing biologics approvals
• Next-gen device engineering
• Connectivity and remote monitoring integration
• Pharmaceutical partnerships for combination products
By 2030, connected, smart patch injectors will become the fastest-growing product category, exhibiting double-digit adoption.
Regional Insights
North America
Largest market, driven by diabetes prevalence, biologics uptake, and smart med-tech innovation.
Europe
Strong presence of device manufacturers and pharma leaders focusing on autoimmune and oncology therapies.
Asia-Pacific
Fastest-growing region (CAGR > 14%) due to large diabetic population, rising health tech startups, and expanding biosimilar manufacturing.
Latin America & Middle East
Growth supported by chronic disease management programs and adoption of wearable insulin delivery technologies.
Conclusion
The On-Body Drug Delivery Devices Market is poised for extraordinary growth as chronic conditions rise and biologics become central to global therapy pipelines. Innovations in connectivity, microneedle systems, and wearable pump injectors will create significant white space opportunities for med-tech and biopharma companies aiming to lead in digital therapeutics and patient-centric care.
This report is also available in the following languages : Japanese (体内薬物送達デバイスのホワイトスペース分析市場), Korean (신체 약물 전달 장치 공백 분석 시장), Chinese (体外给药装置市场空白分析), French (Analyse des opportunités de marché des dispositifs d'administration de médicaments sur le corps), German (Marktanalyse für On-Body-Arzneimittelverabreichungssysteme), and Italian (Analisi del mercato degli spazi bianchi nei dispositivi di somministrazione di farmaci sul corpo), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73462
Related Reports
Diabetes Drug Delivery Devices Market
https://exactitudeconsultancy.com/reports/73469/diabetes-drug-delivery-devices-market
Needle Free Drug Delivery Devices Market
https://exactitudeconsultancy.com/reports/73478/needle-free-drug-delivery-devices-market
Connected Drug Delivery Devices Market
https://exactitudeconsultancy.com/reports/73439/connected-drug-delivery-devices-market
Ocular Drug Delivery Devices Market
https://exactitudeconsultancy.com/reports/72671/ocular-drug-delivery-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release On-Body Drug Delivery Devices Market to Reach USD 46.7 Billion by 2030 here
News-ID: 4292647 • Views: …
More Releases from Exactitude Consultancy
Pharmaceutical Vials Market Set to Hit USD 18.8 Billion by 2030
The Global Pharmaceutical Vials Market is experiencing accelerated growth driven by expanding production of biologics, vaccines, and sterile injectable medicines. According to Exactitude Consultancy, the market is expected to reach USD 18.8 billion by 2030, rising from USD 10.2 billion in 2023, representing a CAGR of 8.2% between 2024 and 2030.
This rise is supported by stronger regulatory focus on sterility, increasing global vaccination drives, expansion of fill-finish capacities, and the…
Container Closure Integrity Testing Market Surges to USD 987 Million by 2030
The global Container Closure Integrity Testing (CCIT) Market is witnessing accelerated growth as pharmaceutical and biotech companies increase investments in sterile packaging quality, biologics, and parenteral drug manufacturing. According to Exactitude Consultancy's latest analysis, the market is projected to reach USD 987 million by 2030, up from USD 540 million in 2023, growing at a CAGR of 9.1% from 2024 to 2030.
CCIT has become a mission-critical process for ensuring microbial…
Podcasting Market Continues Rapid Expansion as Audio Streaming, Influencer Cultu …
Global Podcasting Market Expected to Reach USD 214.3 Billion by 2034, Driven by Growth in Digital Media Consumption and Monetization Models
Snippet (Teaser)
The Podcasting Market is experiencing a powerful resurgence as listeners increasingly shift to on-demand audio content for news, entertainment, education, and professional development. The rise of smartphones, smart speakers, 5G connectivity, and creator-focused monetization is fueling robust global growth through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/reports/74603/ai-chip-market
Podcasting…
Digital Detox Apps Market Grows as Consumers Seek Balance, Mental Well-Being, an …
Global Digital Detox Apps Market Expected to Reach USD 3.9 Billion by 2034, Driven by Rising Smartphone Fatigue and Demand for Healthy Digital Habits
Snippet (Teaser)
The Digital Detox Apps Market is rapidly expanding as people across the globe seek healthier relationships with technology. With rising screen fatigue, mental-health concerns, and the push for mindful digital usage, digital detox apps are becoming mainstream tools for well-being, productivity, and lifestyle improvement.
Download Full PDF…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research.
The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth.
The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically…
